contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


chemotech-retrans-clinical-study-on-tse-in-equine-sarcoid-mgmt-to-be-presented-at-the-upcoming-ecvs-meeting

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Scandinavian ChemoTech är ett svenskt bolag som utvecklar och marknadsför medicinteknologi baserad på elektrokemoterapi för behandling av cancer. Bolaget erbjuder system och lösningar till kliniker inom onkologi och veterinärmedicin och har verksamhet på internationella marknader, bland annat i Indien och Sydostasien. Bolaget grundades 2015 och har sitt huvudkontor i Lund, Sverige.

Scandinavian ChemoTech

Retransmission of the press release that was published, with the associated MAR label, on February 18th, 2026 at 20:50.Scandinavian ChemoTech today announced that a clinical study conducted ...

<div class="abstract">Retransmission of the press release that was published, with the associated MAR label, on February 18th, 2026 at 20:50.Scandinavian ChemoTech today announced that a clinical study conducted &nbsp;by Prof. Cathrine T. Fjordbakk, DVM, PhD, Diplomate ECVS, Diplomate ECVSMR, Professor in Equine Surgery at the Norwegian University of Life Sciences (NMBU), will be presented at the annual scientific meeting of the European College of Veterinary Surgeons (ECVS), in Liverpool, July 2026.The study evaluates the clinical use of Tumour Specific Electroporation™️ (TSE) within the vetIQure™️ platform for equine sarcoid management.</div>Presentation at this conference, which is the largest scientific veterinary speciality conference in Europe, supports growing scientific interest in Tumour Specific Electroporation™️ as an innovative modality in equine sarcoid management. Details regarding case selection, treatment protocols, and outcomes including long-term follow up (&gt; 8 months) will be presented.&nbsp;Prof. Fjordbakk commented: "I am honored to have been given the opportunity to present my findings on the management of equine sarcoids using Tumour Specific Electroporation therapy. Having treated sarcoids with this modality for more than 1.5 years, I value TSE as an important addition to the therapeutic options available in clinical practice. I am happy to continue working with this therapy and look forward to sharing further scientific insights with the community."&nbsp;Additional scientific discussion is planned in connection with the 35th Annual Scientific Meeting of the European College of Veterinary Surgeons (ECVS), taking place 9-11 July 2026 in Liverpool, United Kingdom, at the ACC Arena and Convention Centre Liverpool - one of Europe's leading veterinary surgical congresses gathering specialists, researchers, and clinical leaders from across the world.&nbsp;VQ Animal Care remains committed to supporting evidence-based innovation in veterinary medicine and advancing responsible clinical research in collaboration with academic and clinical partners.&nbsp;VQ Animal Care's Tumor-Specific Electroporation (TSE) technology provides several important advantages for treating equine tumors and <a href="https://www.swedbank-aktiellt.se/$out?u=https%3A%2F%2Fwww.google.com%2Fsearch%3Fclient%3Dfirefox-b-d%26q%3DSarcoids%26mstk%3DAUtExfDBH66FQHd_lwLhzqxXsiIfvenpy_YAl_Oe61QVGg9O1vcCnbCtiDumrjxc87z_UqD76SUAQfDp5DeVvV8ZzvB2WyUxSAQo9h5boj4g-zQrHa74Dg3dtFk1L0yze4vbZuFPfbhh_1aZ_EeNsjiYucQZvqy6OqrPCiGoeU7xBaHj8oI%26csui%3D3%26ved%3D2ahUKEwjw4pCbraSRAxWbhf0HHXTXO-UQgK4QegQIBBAB&amp;t=sarcoids&amp;i=%2Ftelegram%2FiCLbSsqT&amp;c=74083_74083_956735442_7EA3">sarcoids</a>:<ul type="disc">	<li>Often performed without general anesthesia, reducing risk and improving safety.</li>	<li>Tissue-sparing and minimally destructive, resulting in less scarring and better cosmetic and functional outcomes.</li>	<li>Lower stress for horses thanks to shorter, less invasive procedures and fast recovery.</li>	<li>More cost-efficient for owners, with fewer resources needed and lower overall treatment costs.</li>	<li>Accessible in a wide range of clinical settings, as many treatments can be performed with the horse standing under light sedation.</li></ul>&nbsp;<div></div>

ChemoTech: (RETRANS) Clinical Study on TSE in Equine Sarcoid Mgmt. to be presented at the upcoming ECVS Meeting.